It should be noted that vitamin D protects against NAFLD, ameliorating hepatic steatosis owing to obesity-induced dyslipidemia, by reducing plasma lipid uptake through fatty acid translocase (FAT/CD36) and increasing hepatic mitochondrial β-oxidation via the PPARα signaling pathway [218] (Table 6). Here, CD36 is linked to obesity due to melanocortin 4 receptor deficiency.